Board of Trustees 2017–2018
Mark S. Soberman, MD, MBA, FACS
Medical Director, Oncology Service Line
Chief Physician Executive, Monocacy Health Partners
Frederick Regional Health System
Mark Soberman, MD, MBA, FACS, is medical director, Oncology Service Line and Chief Physician Executive, Monocacy Health Partners, and a member of the Board of Managers of the Frederick Integrated Healthcare Network at Frederick Regional Health System in Frederick, Maryland. He is a reviewer for the Annals of Thoracic Surgery and a member of the Society of Thoracic Surgeons, Southern Thoracic Surgical Association, General Thoracic Surgical Club, American Association for Physician Leadership, American College of Healthcare Executives, and the American Society of Clinical Oncology.
Previously, he served as vice-chair of the Department of Surgery; director, Section of Thoracic Oncology; and director, Section of Thoracic Surgery, at the Washington Hospital Center. He has also held the positions of director, Division of Thoracic Surgery at Georgetown University Hospital and director, Section of Thoracic Surgery at Sibley Memorial Hospital. His academic appointments include Clinical Associate Professor of Surgery at Georgetown University School of Medicine and Clinical Assistant Professor of Surgery at George Washington University School of Medicine.
Dr. Soberman earned his undergraduate degree in Biology at Washington University in St. Louis with Eliot Honors, and graduated from the Emory University School of Medicine. After completing a residency in General Surgery at Emory University Affiliated Hospitals, he went on to complete his residency Cardiothoracic Surgery at George Washington University and an advanced fellowship in General Thoracic Surgery at the Cleveland Clinic.
Dr. Soberman has been the recipient of two Alley-Sheridan Fellowships from the Thoracic Surgery Foundation for Research and Education, completing executive courses in Health Policy at Harvard’s John F. Kennedy School of Government. In 2009, he completed an MBA at the Darden School of Business, University of Virginia, receiving a faculty award for academic excellence. In 2014, he attended Professor Michael Porter’s Intensive Value-Based Health Care Delivery Symposium at Harvard Business School.
Dr. Soberman has lectured extensively, both nationally and internationally on topics relating to thoracic oncology and more recently, value-based health care delivery. His professional interests include the study value-based healthcare, innovative care delivery models and innovative payment models, value in oncology, and multidisciplinary cancer care models.
Thomas A. Gallo, MS
Virginia Cancer Institute
Thomas A. Gallo, MS, is executive director of the Virginia Cancer Institute in Richmond, Virginia. In this role, he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees. Among his responsibilities are strategic planning, operations, financial management, personnel management, and purchasing.
Mr. Gallo has been an active member of the Association of Community Cancer Centers (ACCC) for more than 10 years. He currently serves on ACCC’s Investment Committee and Governmental Affairs Committee, which he previously chaired. He has presented at a number of ACCC Annual Meetings, and has previously served on the ACCC Board of Trustees (2004-2005).
In addition to his involvement with ACCC, Mr. Gallo is a member of the Board of Trustees of the Richmond Academy of Medicine; a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematology & Oncology Managers; a member of the Virginia Association of Hematologists and Oncologists (VAHO); and a former Board Member of the Richmond MGMA.
Prior to entering the healthcare field, Mr. Gallo was a commercial banker with Marine Midland Bank in New York City and Central Fidelity Bank in Richmond, Virginia.
He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance from Virginia Commonwealth University, where he was a Dean’s Scholar.
Randall A. Oyer, MD
Oncology Program, Medical Director
Lancaster General Hospital
Randall A. Oyer, MD, is Program Director in Oncology at Lancaster General Health, a community health system in Lancaster, Pennsylvania. Dr. Oyer divides his time among patient care, program administration, program development, and community outreach. He works closely with a multidisciplinary team comprising nursing, social work, pharmacy, chaplaincy and medical specialties focused on strategy, implementation, and patient care. Lancaster General opened the Ann B. Barshinger Cancer Institute in July 2013 using an integrated care model and working closely with its academic partner, the Abramson Cancer Center of the University of Pennsylvania.
Dr. Oyer is an active member of ACCC, attending national and regional meetings, serving on the Governmental Affairs Committee, participating in Capitol Hill visits, and serving as an Advisory Board member for ACCC's Molecular Testing education project. In addition, he has served as a member of the CMS Ambulatory Payment Classification Panel and ASCO’s Clinical Practice Committee.
Dr. Oyer is a graduate of Georgetown University and Georgetown University School of Medicine.
Ali McBride, PharmD, MS, BCPS, BCOP
The University of Arizona Cancer Center
Ali McBride, PharmD, MS, BCPS, is the clinical coordinator of Hematology/Oncology at the University of Arizona Cancer Center. His practice and research interests include acute and chronic leukemias, multiple myeloma, infectious diseases, oncologic emergencies, and pharmacogenomics.
Previously, he served as the stem cell transplant pharmacist at Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State Medical Center and the hematologic malignancies/stem cell transplant pharmacist at Siteman Cancer Center at Barnes-Jewish Hospital.
Dr. McBride has previously served on the Board of Trustees for the Association of Community Cancer Centers. He has been actively involved with the American Society of Health-System Pharmacists (ASHP), Arizona Pharmacy Association (AzPA) and the Hematology Oncology Pharmacy Association (HOPA) for which he served as the chair of the Legislative Affairs Committee.
He received a BS degree in Neurobiology and Physiology from Purdue University, an MS in Biology from Indiana University-Purdue University, and a PharmD degree from the University of Arizona College of Pharmacy.
- Immediate Past President
Jennie R. Crews, MD, MMM, FACP
Medical Director, Seattle Cancer Care Alliance Network
Medical Director, Research Integration at SCCA
Associate Professor of Medicine, Univ. of Washington
Seattle Cancer Care Alliance
Jennie R. Crews, MD, MMM, FACP, is Medical Director, Seattle Cancer Care Alliance Network; Medical Director, Research Integration at Seattle Cancer Care Alliance (SCCA); and Associate Professor of Medicine, University of Washington. Dr. Crews has more than 18 years of experience in oncology in academic, private practice, and hospital-based settings. Previously she served as the Medical Director for Cancer Services in the PeaceHealth Northwest Network, which includes St. Joseph Cancer Center in Bellingham, Washington; PeaceIsland Hospital on San Juan Island, Washington; and PeaceHealth Ketchikan, Alaska. She also served as the Medical Director of the Marion L. Shepard Cancer Center in Washington, N.C., and held appointments as a Consulting Associate in the Department of Medicine, Division of Medical Oncology and Transplantation at Duke, and as an Affiliate Associate Professor in the Department of Medicine at East Carolina University.
Dr. Crews served as ACCC Treasurer (2013-2015), and as ACCC President-Elect (2015-2016). She has served as the President of the North Carolina Oncology Association (NCOA) and as NCOA’s Legislative Liaison to the North Carolina General Assembly. She is on the Editorial Committee for the ACCC Oncology Drug Database, a reviewer for the Journal of Oncology Practice, and a member of the ASCO Practice Guidelines Implementation Network. She has been named to the Best Doctors in America since 2007.
Dr. Crews received her BS degree in Biology with highest honors from the University of North Carolina at Chapel Hill. She earned her MD from Duke University and completed training in internal medicine and oncology at Duke, where she served as assistant chief resident. She is a Fellow in the American College of Physicians and is board certified in internal medicine and medical oncology.
Board of Trustees
- Olalekan Ajayi, PharmD
Oncology Service Line Manager
Welch Cancer Center
Olalekan “Lekan” Ajayi, PharmD, currently serves as the manager for the oncology service line for Welch Cancer Center, Sheridan Cancer and Cardiac Center, Sheridan Memorial Hospital in Sheridan, Wyoming. In this role he oversees both strategic and operational initiatives of the cancer program. He has worked extensively as a clinical pharmacist and an oncology pharmacy manager for seven years.
Dr. Olalekan is passionate about expanding patient access to quality cancer care. He is an active ACCC member and currently serves on the Advisory Committee for the ACCC specialty pharmacy education initiative. Additional, Dr. Olalekan is working with Pro Health International, a West African non-profit organization to bring quality cancer care to underserved populations and to bridge practice gaps between West African medical oncology professionals and their North American counterparts.
He holds a Doctor of Pharmacy degree from the University of Wyoming.
- Catherine Brady-Copertino, BSN, MS, OCN
Executive Director, Geaton and JoAnn DeCesaris Cancer Institute (DCI)
Anne Arundel Medical Center
Catherine Brady-Copertino, BSN, MS, OCN, serves as the executive director of the Geaton and JoAnn DeCesaris Cancer Institute (DCI) at Anne Arundel Medical Center in Annapolis, Maryland. In this role, Catherine provides strategic and operational leadership for the Institute, a Commission on Cancer-approved cancer program that diagnoses more than 1,800 new cancer cases annually and treats more than 300 ambulatory patients each day, making the DCI one of the largest cancer programs in Maryland.
Catherine has presented and published nationally and has served on numerous committees and boards including Governor-appointed membership on the State of Maryland’s Council on Cancer Control, the Maryland Cancer Plan’s Breast Committee, as chair of the Anne Arundel County Health Department’s Conquer Cancer Task Force, John Hopkins Network Clinical Research Steering Committee, Susan G. Komen Grant Review Board, Hospice of the Chesapeake Board of Directors, and the Oncology Nursing Society’s Capitol Gang as a health policy patient and nurse advocate. In addition, she is one of the two founding directors in Global Oncology Services Ireland, Ltd., an oncology medical service provider in Ireland since 2006. Global Oncology provides oncology program development and professional services to the private sector hospitals in Galway and Dublin.
She received her BS degree in Nursing from the Catholic University of America, Washington, D.C., and her MS in Health Care Administration from the University of Maryland. She has been an Oncology Certified Nurse (OCN) for more than 35 years.
- Neal Christiansen, MD
Robert H. Lurie Comprehensive Cancer Center
at Northwestern Medical Faculty Foundation
Lake Forest, Illinois
Neal P. Christiansen, MD, is a member of Northwestern Medical Group serving as a Health Service Clinician in Hematology and Oncology at Northwestern Lake Forest Hospital in Lake Forest, Illinois, and at Grayslake Cancer Center. Previously, Dr. Christiansen was an Associate Professor and Fellowship Program Director at the Medical University of South Carolina in Charleston, S.C., from 2009–2014.
Dr. Christiansen has been active in academic medicine with faculty positions at the University of Minnesota, University of Tennessee – Memphis, Roswell Park Cancer Institute, and the University of South Carolina School of Medicine in Columbia, S.C. He also was in private practice from 1999–2009 with South Carolina Oncology Associates, P.A. in Columbia. His interests and research through his career has included stem cell transplantation; immunotherapy; leukemia; myeloma; solid tumor oncology including breast, lung and pancreas; and health disparity. Post-graduate education and patient education have also been a major focus.
Dr. Christiansen earned his MD degree at Washington University School of Medicine in St. Louis and completed his internship and residency in Internal Medicine at Michael Reese Hospital and Clinic in Chicago, followed by fellowship in Medical Oncology at the University of Minnesota, Minneapolis.
- Melanie Feinberg
Director, Oncology Quality
Maine Medical Center/MaineHealth
Melanie Feinberg is Director, Oncology Quality, Maine Medical Center/MaineHealth. In this role, for the past 15 years she has overseen the quality program for both Maine Medical Center and MaineHealth Oncology. Ms. Feinberg has extensive experience in developing systems to measure and benchmark quality. The successful completion of the MaineHealth multi-hospital tumor registry network ensures that there will be a single source for clinical outcomes information to inform development of a regional oncology care delivery model.
She is President-Elect of the Cancer Registrars Association of Maine and a member of the ACCC Education Committee. In addition Ms. Feinberg serves as Chair of the Maine Cancer Foundation’s Treatment Work Group and is a board member of Hospice of Southern Maine (HSM), as well as a working member of HSM’s Quality of Care Committee.
- Krista Nelson, MSW, LCSW, OSW-C
Compassion with Providence Health & Services
Providence Cancer Center
Krista Nelson, MSW, LCSW, OSW-C, is an oncology social worker serving as program manager for Quality and Research of Cancer Support Services and recently assumed a new role as the clinical manager of Compassion with Providence Health & Services in Portland, Oregon. She has been part of the Providence Health & Services oncology program since 1997, providing psychosocial care to those with cancer and their families. She has specialized in many cancer types over the years and is interested in the effect of cancer on the family.
Ms. Nelson is a past president of the Board of Directors of the Association of Oncology Social Work (AOSW) and past invited director of the American Psychosocial Oncology Society (APOS). She loves being a part of the national discussion involving the psychosocial care of people with cancer.
She has presented at local and national conferences on issues of survivorship, palliative care, breast and lung cancer, distress screening, and children who have a parent with cancer.
Additionally, Ms. Nelson serves as an invited director on the Board of Directors of the National Accreditation Program for Breast Centers (NAPBC) and as a director of the American Clinical Social Work Association. In 2015, she was named as a finalist in the Schwartz Center Compassionate Caregiver of the Year Award.
She has been a volunteer facilitator at retreats for women with breast cancer and programs that support grieving children. She also has volunteered annually on medical relief teams to Haiti since 2009.
- Laeton Pang, MD, MPH, FACR, FACRO
Pacific Radiation Oncology, LLC
Laeton Pang, MD, MPH, FACR, FACRO, is a radiation oncologist with Pacific Radiation Oncology, LLC. A leader in Hawaii’s oncology professional community, Dr. Pang is a founding member of the Hawaii Society of Clinical Oncology (HSCO), a clinical instructor for the John A. Burns School of Medicine, and serves as the radiation oncology representative to the Hawaii Medicare Carrier Advisory Committee (CAC).
Dr. Pang has served as President for the Hawaii Society of Clinical Oncology, Board Member for the American Cancer Society, Medical Director for Leeward Radiation Oncology and Vice-Chairman of the Cancer Institute. Dr. Pang believes that his job is his calling and he lives and breathes advocacy for cancer patients and improvement of cancer care for Hawaii and the world.
He is a graduate of Iolani School, University of Hawaii-Manoa, Tulane University Schools of Medicine and Public Health, and completed his residency at the University of Virginia Health Sciences Center.
- Kashyap Patel, MD
Carolina Blood & Cancer Care Associates
Rock Hill, South Carolina
Kashyap Patel, MD, Managing Partner, Carolina Blood & Cancer Care Associates, is a board certified hematologist/oncologist who specializes in palliative care. He is a full-time practicing medical oncologist with 20 years of experience working directly with cancer patients.
Dr. Patel is a past president of the South Carolina Oncology Society. He serves on the board of the Community Oncology Alliance (COA), on the advisory board for Medicaid HMOs, and has been a Carrier Advisory Committee (CAC) member for the DHHS (SC), Palmetto GBA. Dr. Patel has a special interest in healthcare policy and economics and new alternative payment models.
Dr. Patel completed his residency at Jamaica Hospital in New York City and a fellowship in Hematology and Medical Oncology at Thomas Jefferson University Hospital in Philadelphia. He is a certified trainer for physicians on “Education in Palliative and End of Life Care,” and has published journal articles and presented both nationally and internationally.
- David A. Penberthy, MD, MBA
Medical Director, Radiation Oncology
Southside Regional Medical Center
David A. Penberthy, MD, MBA, serves as the Medical Director of Radiation Oncology and Cancer Committee Chairman at Southside Regional Medical Center (SRMC) in Petersburg, Virginia. During his tenure as chairman, Dr. Penberthy led SRMC’s oncology program through two American College of Surgeons Commission on Cancer (CoC) accreditation surveys resulting in cancer program accreditation, each time earning an Outstanding Achievement Award, an accolade achieved by only a small fraction of community oncology programs in the country. Dr Penberthy is also president of Virginia Radiation Oncology Associates, Inc., a private medical practice based in Richmond, Virginia, where he has practiced since completing residency at the University of Virginia in 2002.
Dr. Penberthy is enthusiastic about patient care and is intensely engaged in providing state-of-the-art, patient-centered, compassionate oncology care. His interests also include the study of advanced computing systems and how this emerging technology may affect healthcare in the near future.
After earning his MD degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital. He then served as a U.S. Navy Flight Surgeon with Fighter Squadron 101 in Oceana, Virginia. He completed his MBA from the Darden School of Business at the University of Virginia in 2011. His strong interest and knowledge of technology eventually led him to the field of radiation oncology.
- Gail W. Probst, MS, RN, AOCN, NE-BC
Director, Cancer Services
Huntington Hospital of Northwell Health
Huntington, New York
Gail Probst, MS, RN, AOCN, NE-BC, is director of Cancer Services at Huntington Hospital, Huntington, New York. She has dedicated her entire career to the nursing profession and the last 27 years exclusively to oncology nursing. Ms. Probst was instrumental in the hospital obtaining certification and re-certification since 1997 as a Comprehensive Community Cancer Program from the American College of Surgeons Commission on Cancer.
While at Huntington Hospital, Ms. Probst instituted the hospital’s first oncology unit. With the help of several medical oncologists, the Cancer Committee was organized and all policies and procedures for the care of cancer patients were established and implemented. Support groups were developed as well as a robust screening and outreach program. She developed an oncology nursing orientation and competency program for all nurses joining the oncology staff. She has taught extensively on chemotherapy, biotherapy, and many subjects related to cancer nursing and cancer care.
She has contributed to ACCC’s journal Oncology Issues on “A Community-Based Breast Cancer Risk Assessment Model.” She has also served on the Advisory Committee for the ACCC Molecular Testing education initiative.
Ms. Probst believes that we are in a dynamic period of healthcare where education will play a vital role in patients receiving optimal cancer care. Further, she believes that in the era of personalized medicine, it is important that we educate physicians, nurses, and patients about the role genetics and genomics will play in the new evolving diagnostic tools, prognostic biomarkers, and medical treatments. She believes it is incumbent on healthcare professionals to strive to educate patients on wellness so that they are better able to advocate for good health for themselves.
Ms. Probst received her MS degree in Nursing from the State University of New York at Stony Brook.
- Cecilia R. Zapata, MS, MHA
Director, Strategic Outreach and Affiliate Network Programs
Seattle Cancer Care Alliance (SCCA)
Cecilia Zapata, MS, MHA, is the director of Strategic Outreach and Affiliate Network programs at Seattle Cancer Care Alliance (SCCA) in Seattle, Washington. In this role, Ms. Zapata has expanded the program to include affiliates across the Pacific Northwest and in Hawaii.
A long-time active ACCC member, Ms. Zapata is currently serving on the Board of Trustees and on the Membership Committee, and previously chaired the ACCC Education Committee. In addition, she is active in the National Comprehensive Cancer Network (NCCN) Affiliation Forum and the Association of Cancer Executives (ACE).
Prior to joining the SCCA, Ms. Zapata was senior project manager for the Planning and Strategic Development Program at Fred Hutchinson Cancer Research Center (FHCRC). She was also the program administrator for the Molecular Pharmacology Program, under the direction of Dr. Stephen Friend and Dr. Lee Hartwell, in the Clinical Research Division at FHCRC, and has been with FHCRC/SCCA for a total of 26 years. In her role as director of Strategy Development, she led the SCCA through an 18-month strategic planning process; successfully identifying primary focus programs for the next five years.
Ms. Zapata earned her MS degree in Cultural/Social Anthropology and MHA from the University of Washington and is currently certifying as a professional coach.